Clinical Trial Update: A Platform Study in Non-Small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]

View source ↗

Summary

A platform trial in advanced or metastatic non-small cell lung cancer is currently recruiting for Phase 1 and Phase 2 cohorts sponsored by AstraZeneca.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: AstraZeneca | Conditions: Advanced or Metastatic Non-small Cell Lung Cancer | Phase 1, Phase 2 | Status: RECRUITING